Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma

Histology and Histopathology

Volumn 28, Issue 4, 2013, Pages 437-451

  Gailhouste, Luc ^a   Ochiya, Takahiro ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Hepatocellular carcinoma; MicroRNA; Oncogene; Tumor suppressor

Indexed keywords

MICRORNA; TUMOR MARKER;

ANIMAL; CELL TRANSFORMATION; DISEASE COURSE; GENE EXPRESSION REGULATION; GENE THERAPY; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; PROGNOSIS; REVIEW;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC THERAPY; HUMANS; LIVER NEOPLASMS; MICRORNAS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84876450968     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (128)

1. Aravalli R.N., Steer C.J. and Cressman E.N. (2008). Molecular mechanisms of hepatocellular carcinoma. Hepatology 48, 2047-2063.
2. Bai S., Nasser M.W., Wang B., Hsu S.H., Datta J., Kutay H., Yadav A., Nuovo G., Kumar P. and Ghoshal K. (2009). MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J. Biol. Chem. 284, 32015-32027.
3. Banaudha K., Kaliszewski M., Korolnek T., Florea L., Yeung M.L., Jeang K.T. and Kumar A. (2011). MicroRNA silencing of tumor suppressor DLC-1 promotes efficient hepatitis C virus replication in primary human hepatocytes. Hepatology 53, 53-61.
4. Bartel D.P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
5. Bartel D.P. (2009). MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233.
6. Bhattacharya S.D., Garrison J., Guo H., Mi Z., Markovic J., Kim V.M. and Kuo P.C. (2010). Micro-RNA-181a regulates osteopontin-dependent metastatic function in hepatocellular cancer cell lines. Surgery 148, 291-297.
7. Borel F., Konstantinova P. and Jansen P.L. (2012). Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma. J. Hepatol. 56, 1371-1383.
8. Boutz D.R., Collins P.J., Suresh U., Lu M., Ramirez C.M., Fernandez-Hernando C., Huang Y., Abreu Rde S., Le S.Y., Shapiro B.A., Liu A.M., Luk J.M., Aldred S.F., Trinklein N.D., Marcotte E.M. and Penalva L.O. (2011). Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122. J. Biol. Chem. 286, 18066-18078.
9. Braconi C., Huang N. and Patel T. (2010). MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. Hepatology 51, 881-890.
10. Budhu A., Jia H.L., Forgues M., Liu C.G., Goldstein D., Lam A., Zanetti K.A., Ye Q.H., Qin L.X., Croce C.M., Tang Z.Y. and Wang X.W. (2008). Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 47, 897-907.
11. Buurman R., Gurlevik E., Schaffer V., Eilers M., Sandbothe M., Kreipe H., Wilkens L., Schlegelberger B., Kuhnel F. and Skawran B. (2012). Histone deacetylases activate hepatocyte growth factor signaling by fepressing microRNA-449 in hepatocellular carcinoma cells. Gastroenterology 143, 811-820.
12. Calin G.A. and Croce C.M. (2006). MicroRNA signatures in human cancers. Nat. Rev. Cancer. 6, 857-866.
13. Calin G.A. and Croce C.M. (2007). Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications. J. Clin. Invest. 117, 2059-2066.
14. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M. and Croce C.M. (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA 101, 2999-3004.
15. Chang T.C., Yu D., Lee Y.S., Wentzel E.A., Arking D.E., West K.M., Dang C.V., Thomas-Tikhonenko A. and Mendell J.T. (2008). Widespread microRNA repression by Myc contributes to tumorigenesis. Nat. Genet. 40, 43-50.
16. Chen X.M. (2009). MicroRNA signatures in liver diseases. World J. Gastroenterol. 15, 1665-1672.
17. Chen C., Ridzon D.A., Broomer A.J., Zhou Z., Lee D.H., Nguyen J.T., Barbisin M., Xu N.L., Mahuvakar V.R., Andersen M.R., Lao K.Q., Livak K.J. and Guegler K.J. (2005). Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 33, e179.
18. Chen P.J., Yeh S.H., Liu W.H., Lin C.C., Huang H.C., Chen C.L., Chen D.S. and Chen P.J. (2012). Androgen pathway stimulates MicroRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis. Hepatology 56, 632-643.
19. Cheng J., Zhou L., Xie Q.F., Xie H.Y., Wei X.Y., Gao F., Xing C.Y., Xu X., Li L.J. and Zheng S.S. (2010). The impact of miR-34a on protein output in hepatocellular carcinoma HepG2 cells. Proteomics 10, 1557-1572.
20. Cheung O., Puri P., Eicken C., Contos M.J., Mirshahi F., Maher J.W., Kellum J.M., Min H., Luketic V.A. and Sanyal A.J. (2008). Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology 48, 1810-1820.
21. Chung G.E., Yoon J.H., Myung S.J., Lee J.H., Lee S.H., Lee S.M., Kim S.J., Hwang S.Y., Lee H.S. and Kim C.Y. (2010). High expression of microRNA-15b predicts a low risk of tumor recurrence following curative resection of hepatocellular carcinoma. Oncol. Rep. 23, 113-119.
22. Connolly E.C., Van Doorslaer K., Rogler L.E. and Rogler C.E. (2010). Overexpression of miR-21 promotes an in vitro metastatic phenotype by targeting the tumor suppressor RHOB. Mol. Cancer Res. 8, 691-700.
23. Datta J., Kutay H., Nasser M.W., Nuovo G.J., Wang B., Majumder S., Liu C.G., Volinia S., Croce C.M., Schmittgen T.D., Ghoshal K. and Jacob S.T. (2008). Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res. 68, 5049-5058.
24. Ding J., Huang S., Wu S., Zhao Y., Liang L., Yan M., Ge C., Yao J., Chen T., Wan D., Wang H., Gu J., Yao M., Li J., Tu H. and He X. (2010). Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat. Cell Biol. 12, 390-399.
25. El-Serag H.B. and Rudolph K.L. (2007). Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132, 2557-2576.
26. Elyakim E., Sitbon E., Faerman A., Tabak S., Montia E., Belanis L., Dov A., Marcusson E.G., Bennett C.F., Chajut A., Cohen D. and Yerushalmi N. (2010). hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy. Cancer Res. 70, 8077-8087.
27. Esquela-Kerscher A. and Slack F.J. (2006). Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269.
28. Faggad A., Budczies J., Tchernitsa O., Darb-Esfahani S., Sehouli J., Muller B.M., Wirtz R., Chekerov R., Weichert W., Sinn B., Mucha C., Elwali N.E., Schafer R., Dietel M. and Denkert C. (2010). Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression. J. Pathol. 220, 382-391.
29. Fang Y., Xue J.L., Shen Q., Chen J. and Tian L. (2012). MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma. Hepatology 55, 1852-1862.
30. Farazi P.A. and DePinho R.A. (2006). Hepatocellular carcinoma pathogenesis: from genes to environment. Nat. Rev. Cancer 6, 674-687.
31. Fornari F., Gramantieri L., Ferracin M., Veronese A., Sabbioni S., Calin G.A., Grazi G.L., Giovannini C., Croce C.M., Bolondi L. and Negrini M. (2008). MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 27, 5651-5661.
32. Fornari F., Gramantieri L., Giovannini C., Veronese A., Ferracin M., Sabbioni S., Calin G.A., Grazi G.L., Croce C.M., Tavolari S., Chieco P., Negrini M. and Bolondi L. (2009). MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res. 69, 5761-5767.
33. Fornari F., Milazzo M., Chieco P., Negrini M., Calin G.A., Grazi G.L., Pollutri D., Croce C.M., Bolondi L. and Gramantieri L. (2010). MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res. 70, 5184-5193.
34. Furuta M., Kozaki K.I., Tanaka S., Arii S., Imoto I. and Inazawa J. (2010). miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 31, 766-776.
35. Gailhouste L., Gómez-Santos L. and Ochiya T. (2013). Potential applications of miRNAs as diagnostic and prognostic markers in liver cancer. Front. Biosci. 18, 199-223.
36. Gao Y., Schug J., McKenna L.B., Le Lay J., Kaestner K.H. and Greenbaum L.E. (2011). Tissue-specific regulation of mouse microRNA genes in endoderm-derived tissues. Nucleic Acids Res. 39, 454-463.
37. Garofalo M., Di Leva G., Romano G., Nuovo G., Suh S.S., Ngankeu A., Taccioli C., Pichiorri F., Alder H., Secchiero P., Gasparini P., Gonelli A., Costinean S., Acunzo M., Condorelli G. and Croce C.M. (2009). miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell 16, 498-509.
38. Gatfield D., Le Martelot G., Vejnar C.E., Gerlach D., Schaad O., Fleury-Olela F., Ruskeepaa A.L., Oresic M., Esau C.C., Zdobnov E.M. and Schibler U. (2009). Integration of microRNA miR-122 in hepatic circadian gene expression. Genes Dev. 23, 1313-1326.
39. Gramantieri L., Ferracin M., Fornari F., Veronese A., Sabbioni S., Liu C.G., Calin G.A., Giovannini C., Ferrazzi E., Grazi G.L., Croce C.M., Bolondi L. and Negrini M. (2007). Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res. 67, 6092-6099.
40. Gramantieri L., Fornari F., Callegari E., Sabbioni S., Lanza G., Croce C.M., Bolondi L. and Negrini M. (2008). MicroRNA involvement in hepatocellular carcinoma. J. Cell. Mol. Med. 12, 2189-2204.
41. Gramantieri L., Fornari F., Ferracin M., Veronese A., Sabbioni S., Calin G.A., Grazi G.L., Croce C.M., Bolondi L. and Negrini M. (2009). MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. Clin. Cancer Res. 15, 5073-5081.
42. Griffiths-Jones S. (2004). The microRNA Registry. Nucleic Acids Res. 32, D109-111.
43. Hanoun N., Delpu Y., Suriawinata A.A., Bournet B., Bureau C., Selves J., Tsongalis G.J., Dufresne M., Buscail L., Cordelier P. and Torrisani J. (2010). The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis. Clin. Chem. 56, 1107-1118.
44. He X.X., Chang Y., Meng F.Y., Wang M.Y., Xie Q.H., Tang F., Li P.Y., Song Y.H. and Lin J.S. (2012). MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene 31, 3357-3369.
45. Hou Y.Y., Cao W.W., Li L., Li S.P., Liu T., Wan H.Y., Liu M., Li X. and Tang H. (2011). MicroRNA-519d targets MKi67 and suppresses cell growth in the hepatocellular carcinoma cell line QGY-7703. Cancer Lett. 307, 182-190.
46. Hsu S.H., Wang B., Kota J., Yu J., Costinean S., Kutay H., Yu L., Bai S., La Perle K., Chivukula R.R., Mao H., Wei M., Clark K.R., Mendell J.R., Caligiuri M.A., Jacob S.T., Mendell J.T. and Ghoshal K. (2012). Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J. Clin. Invest. 122, 2871-2883.
47. Huang N., Lin J., Ruan J., Su N., Qing R., Liu F., He B., Lv C., Zheng D. and Luo R. (2012). MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3. FEBS Lett. 586, 884-891.
48. Imam J.S., Buddavarapu K., Lee-Chang J.S., Ganapathy S., Camosy C., Chen Y. and Rao M.K. (2010). MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers. Oncogene 29, 4971-4979.
49. Ivanovska I., Ball A.S., Diaz R.L., Magnus J.F., Kibukawa M., Schelter J.M., Kobayashi S.V., Lim L., Burchard J., Jackson A.L., Linsley P.S. and Cleary M.A. (2008). MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol. Cell. Biol. 28, 2167-2174.
50. Ji J. and Wang X.W. (2009). New kids on the block: diagnostic and prognostic microRNAs in hepatocellular carcinoma. Cancer Biol. Ther. 8, 1686-1693.
51. Ji J., Shi J., Budhu A., Yu Z., Forgues M., Roessler S., Ambs S., Chen Y., Meltzer P.S., Croce C.M., Qin L.X., Man K., Lo C.M., Lee J., Ng I.O., Fan J., Tang Z.Y., Sun H.C. and Wang X.W. (2009). MicroRNA expression, survival, and response to interferon in liver cancer. N. Engl. J. Med. 361, 1437-1447.
52. Ji J., Zhao L., Budhu A., Forgues M., Jia H.L., Qin L.X., Ye Q.H., Yu J., Shi X., Tang Z.Y. and Wang X.W. (2010). Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma. J. Hepatol. 52, 690-697.
53. Jopling C.L., Yi M., Lancaster A.M., Lemon S.M. and Sarnow P. (2005). Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309, 1577-1581.
54. Kent O.A. and Mendell J.T. (2006). A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 25, 6188-6196.
55. Kondo Y., Kanai Y., Sakamoto M., Mizokami M., Ueda R. and Hirohashi S. (2000). Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis--A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma. Hepatology 32, 970-979.
56. Kosaka N., Iguchi H. and Ochiya T. (2010). Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci. 101, 2087-2092.
57. Kosaka N., Iguchi H., Yoshioka Y., Hagiwara K., Takeshita F. and Ochiya T. (2012). Competitive interactions of cancer cells and normal cells via secretory microRNAs. J. Biol. Chem. 287, 1397-1405.
58. Kota J., Chivukula R.R., O'Donnell K.A., Wentzel E.A., Montgomery C.L., Hwang H.W., Chang T.C., Vivekanandan P., Torbenson M., Clark K.R., Mendell J.R. and Mendell J.T. (2009). Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137, 1005-1017.
59. Krutzfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., Manoharan M. and Stoffel M. (2005). Silencing of microRNAs in vivo with 'antagomirs'. Nature 438, 685-689.
60. Ladeiro Y., Couchy G., Balabaud C., Bioulac-Sage P., Pelletier L., Rebouissou S. and Zucman-Rossi J. (2008). MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 47, 1955-1963.
61. Lagos-Quintana M., Rauhut R., Yalcin A., Meyer J., Lendeckel W. and Tuschl T. (2002). Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12, 735-739.
62. Lan F.F., Wang H., Chen Y.C., Chan C.Y., Ng S.S., Li K., Xie D., He M.L., Lin M.C. and Kung H.F. (2011). Hsa-let-7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c-Myc and upregulation of p16(INK4A). Int. J. Cancer 128, 319-331.
63. Le Sage C., Nagel R., Egan D.A., Schrier M., Mesman E., Mangiola A., Anile C., Maira G., Mercatelli N., Ciafre S.A., Farace M.G. and Agami R. (2007). Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. Embo J. 26, 3699-3708.
64. Lee R.C., Feinbaum R.L. and Ambros V. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-854.
65. Lewis B.P., Burge C.B. and Bartel D.P. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20.
66. Li N., Fu H., Tie Y., Hu Z., Kong W., Wu Y. and Zheng X. (2009a). miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett. 275, 44-53.
67. Li Y., Tan W., Neo T.W., Aung M.O., Wasser S., Lim S.G. and Tan T.M. (2009b). Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci. 100, 1234-1242.
68. Li J., Fu H., Xu C., Tie Y., Xing R., Zhu J., Qin Y., Sun Z. and Zheng X. (2010a). miR-183 inhibits TGF-beta1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells. BMC Cancer 10, 354.
69. Li L.M., Hu Z.B., Zhou Z.X., Chen X., Liu F.Y., Zhang J.F., Shen H.B., Zhang C.Y. and Zen K. (2010b). Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res. 70, 9798-9807.
70. Li D., Liu X., Lin L., Hou J., Li N., Wang C., Wang P., Zhang Q., Zhang P., Zhou W., Wang Z., Ding G., Zhuang S.M., Zheng L., Tao W. and Cao X. (2011a). MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. J. Biol. Chem. 286, 36677-36685.
71. Li J., Wang Y., Yu W., Chen J. and Luo J. (2011b). Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance. Biochem. Biophys. Res. Commun. 406, 70-73.
72. Liang L., Wong C.M., Ying Q., Fan D.N., Huang S., Ding J., Yao J., Yan M., Li J., Yao M., Ng I.O. and He X. (2010). MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2. Hepatology 52, 1731-1740.
73. Lin C.J., Gong H.Y., Tseng H.C., Wang W.L. and Wu J.L. (2008). miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines. Biochem. Biophys. Res. Commun. 375, 315-320.
74. Lin J., Huang S., Wu S., Ding J., Zhao Y., Liang L., Tian Q., Zha R., Zhan R. and He X. (2011). MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma. Carcinogenesis 32, 1641-1647.
75. Liu A.M., Poon R.T. and Luk J.M. (2010). MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. Biochem. Biophys. Res. Commun. 394, 623-627.
76. Liu J., Valencia-Sanchez M.A., Hannon G.J. and Parker R. (2005). MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat. Cell Biol. 7, 719-723.
77. Liu W.H., Yeh S.H., Lu C.C., Yu S.L., Chen H.Y., Lin C.Y., Chen D.S. and Chen P.J. (2009). MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. Gastroenterology 136, 683-693.
78. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R. and Golub T.R. (2005). MicroRNA expression profiles classify human cancers. Nature 435, 834-838.
79. Lujambio A. and Esteller M. (2007). CpG island hypermethylation of tumor suppressor microRNAs in human cancer. Cell Cycle 6, 1455-1459.
80. Lujambio A. and Lowe S.W. (2012). The microcosmos of cancer. Nature 482, 347-355.
81. Ma S., Tang K.H., Chan Y.P., Lee T.K., Kwan P.S., Castilho A., Ng I., Man K., Wong N., To K.F., Zheng B.J., Lai P.B., Lo C.M., Chan K.W. and Guan X.Y. (2010). miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. Cell Stem Cell 7, 694-707.
82. Mayr C., Hemann M.T. and Bartel D.P. (2007). Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315, 1576-1579.
83. Melo S.A., Ropero S., Moutinho C., Aaltonen L.A., Yamamoto H., Calin G.A., Rossi S., Fernandez A.F., Carneiro F., Oliveira C., Ferreira B., Liu C.G., Villanueva A., Capella G., Schwartz S. Jr, Shiekhattar R. and Esteller M. (2009). A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat. Genet. 41, 365-370.
84. Meng F., Henson R., Wehbe-Janek H., Ghoshal K., Jacob S.T. and Patel T. (2007). MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133, 647-658.
85. Meng X.Z., Zheng T.S., Chen X., Wang J.B., Zhang W.H., Pan S.H., Jiang H.C. and Liu L.X. (2011). microRNA expression alteration after arsenic trioxide treatment in HepG-2 cells. J. Gastroenterol. Hepatol. 26, 186-193.
86. Mott J.L. (2009). MicroRNAs involved in tumor suppressor and oncogene pathways: implications for hepatobiliary neoplasia. Hepatology 50, 630-637.
87. Murakami Y., Yasuda T., Saigo K., Urashima T., Toyoda H., Okanoue T. and Shimotohno K. (2006). Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 25, 2537-2545.
88. Pineau P., Volinia S., McJunkin K., Marchio A., Battiston C., Terris B., Mazzaferro V., Lowe S.W., Croce C.M. and Dejean A. (2010). miR-221 overexpression contributes to liver tumorigenesis. Proc. Natl. Acad. Sci. USA 107, 264-269.
89. Salvi A., Sabelli C., Moncini S., Venturin M., Arici B., Riva P., Portolani N., Giulini S.M., De Petro G. and Barlati S. (2009). MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. FEBS J. 276, 2966-2982.
90. Sato F., Tsuchiya S., Meltzer S.J. and Shimizu K. (2011). MicroRNAs and epigenetics. FEBS J. 278, 1598-1609.
91. Sekine S., Ogawa R., Ito R., Hiraoka N., McManus M.T., Kanai Y. and Hebrok M. (2009). Disruption of Dicer1 induces dysregulated fetal gene expression and promotes hepatocarcinogenesis. Gastroenterology 136, 2304-2315 e2301-2304.
92. Shen Q., Cicinnati V.R., Zhang X., Iacob S., Weber F., Sotiropoulos G.C., Radtke A., Lu M., Paul A., Gerken G. and Beckebaum S. (2010). Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion. Mol. Cancer 9, 227.
93. Shigoka M., Tsuchida A., Matsudo T., Nagakawa Y., Saito H., Suzuki Y., Aoki T., Murakami Y., Toyoda H., Kumada T., Bartenschlager R., Kato N., Ikeda M., Takashina T., Tanaka M., Suzuki R., Oikawa K., Takanashi M. and Kuroda M. (2010). Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development. Pathol. Int. 60, 351-357.
94. Shimizu S., Takehara T., Hikita H., Kodama T., Miyagi T., Hosui A., Tatsumi T., Ishida H., Noda T., Nagano H., Doki Y., Mori M. and Hayashi N. (2010). The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. J. Hepatol. 52, 698-704.
95. Su H., Yang J.R., Xu T., Huang J., Xu L., Yuan Y. and Zhuang S.M. (2009). MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res. 69, 1135-1142.
96. Toffanin S., Hoshida Y., Lachenmayer A., Villanueva A., Cabellos L., Minguez B., Savic R., Ward S.C., Thung S., Chiang D.Y., Alsinet C., Tovar V., Roayaie S., Schwartz M., Bruix J., Waxman S., Friedman S.L., Golub T., Mazzaferro V. and Llovet J.M. (2011). MicroRNA-Based Classification of Hepatocellular Carcinoma and Oncogenic Role of miR-517a. Gastroenterology 140, 1618-1628 e1616.
97. Tomimaru Y., Eguchi H., Nagano H., Wada H., Tomokuni A., Kobayashi S., Marubashi S., Takeda Y., Tanemura M., Umeshita K., Doki Y. and Mori M. (2010). MicroRNA-21 induces resistance to the anti-tumour effect of interferon-alpha/5-fluorouracil in hepatocellular carcinoma cells. Br. J. Cancer 103, 1617-1626.
98. Tomimaru Y., Eguchi H., Nagano H., Wada H., Kobayashi S., Marubashi S., Tanemura M., Tomokuni A., Takemasa I., Umeshita K., Kanto T., Doki Y. and Mori M. (2012). Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma. J. Hepatol. 56, 167-175.
99. Tsai W.C., Hsu P.W., Lai T.C., Chau G.Y., Lin C.W., Chen C.M., Lin C.D., Liao Y.L., Wang J.L., Chau Y.P., Hsu M.T., Hsiao M., Huang H.D. and Tsou A.P. (2009). MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology 49, 1571-1582.
100. Villanueva A., Hoshida Y., Toffanin S., Lachenmayer A., Alsinet C., Savic R., Cornella H. and Llovet J.M. (2010). New strategies in hepatocellular carcinoma: genomic prognostic markers. Clin. Cancer Res. 16, 4688-4694.
101. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., Prueitt R.L., Yanaihara N., Lanza G., Scarpa A., Vecchione A., Negrini M., Harris C.C. and Croce C.M. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 103, 2257-2261.
102. Wang Y., Lee A.T., Ma J.Z., Wang J., Ren J., Yang Y., Tantoso E., Li K.B., Ooi L.L., Tan P. and Lee C.G. (2008). Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. J. Biol. Chem. 283, 13205-13215.
103. Wang B., Hsu S.H., Majumder S., Kutay H., Huang W., Jacob S.T. and Ghoshal K. (2010). TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene 29, 1787-1797.
104. Wang X.W., Heegaard N.H. and Orum H. (2012). MicroRNAs in Liver Disease. Gastroenterology 142, 1431-1443.
105. Wightman B., Ha I. and Ruvkun G. (1993). Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75, 855-862.
106. Wong Q.W., Lung R.W., Law P.T., Lai P.B., Chan K.Y., To K.F. and Wong N. (2008). MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Gastroenterology 135, 257-269.
107. Wong Q.W., Ching A.K., Chan A.W., Choy K.W., To K.F., Lai P.B. and Wong N. (2010). MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling. Clin. Cancer Res. 16, 867-875.
108. Wong C.C., Wong C.M., Tung E.K., Au S.L., Lee J.M., Poon R.T., Man K. and Ng I.O. (2011). The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2. Gastroenterology 140, 322-331.
109. Wu J.F., Shen W., Liu N.Z., Zeng G.L., Yang M., Zuo G.Q., Gan X.N., Ren H. and Tang K.F. (2011a). Down-regulation of Dicer in hepatocellular carcinoma. Med. Oncol. 28, 804-809.
110. Wu L., Cai C., Wang X., Liu M., Li X. and Tang H. (2011b). MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells. FEBS Lett. 585, 1322-1330.
111. Wu N., Liu X., Xu X., Fan X., Liu M., Li X., Zhong Q. and Tang H. (2011c). MicroRNA-373, a new regulator of protein phosphatase 6, functions as an oncogene in hepatocellular carcinoma. FEBS J. 278, 2044-2054.
112. Xie Q., Chen X., Lu F., Zhang T., Hao M., Wang Y., Zhao J., McCrae M.A. and Zhuang H. (2012). Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma. Cancer 118, 2431-2442.
113. Xiong Y., Fang J.H., Yun J.P., Yang J., Zhang Y., Jia W.H. and Zhuang S.M. (2010). Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 51, 836-845.
114. Xu T., Zhu Y., Xiong Y., Ge Y.Y., Yun J.P. and Zhuang S.M. (2009). MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology 50, 113-121.
115. Xu C., Liu S., Fu H., Li S., Tie Y., Zhu J., Xing R., Jin Y., Sun Z. and Zheng X. (2010a). MicroRNA-193b regulates proliferation, migration and invasion in human hepatocellular carcinoma cells. Eur. J. Cancer 46, 2828-2836.
116. Xu H., He J.H., Xiao Z.D., Zhang Q.Q., Chen Y.Q., Zhou H. and Qu L.H. (2010b). Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development. Hepatology 52, 1431-1442.
117. Xu J., Wu C., Che X., Wang L., Yu D., Zhang T., Huang L., Li H., Tan W., Wang C. and Lin D. (2011). Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol. Carcinog. 50, 136-142.
118. Yamamoto Y., Kosaka N., Tanaka M., Koizumi F., Kanai Y., Mizutani T., Murakami Y., Kuroda M., Miyajima A., Kato T. and Ochiya T. (2009). MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma. Biomarkers 14, 529-538.
119. Yang F., Yin Y., Wang F., Wang Y., Zhang L., Tang Y. and Sun S. (2010a). miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway. Hepatology 51, 1614-1623.
120. Yang L., Ma Z., Wang D., Zhao W., Chen L. and Wang G. (2010b). MicroRNA-602 regulating tumor suppressive gene RASSF1A is overexpressed in hepatitis B virus-infected liver and hepatocellular carcinoma. Cancer Biol. Ther. 9, 803-808.
121. Yao J., Liang L., Huang S., Ding J., Tan N., Zhao Y., Yan M., Ge C., Zhang Z., Chen T., Wan D., Yao M., Li J., Gu J. and He X. (2010). MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma. Hepatology 51, 846-856.
122. Ying Q., Liang L., Guo W., Zha R., Tian Q., Huang S., Yao J., Ding J., Bao M., Ge C., Yao M., Li J. and He X. (2011). Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma. Hepatology 54, 2064-2075.
123. Zeng C., Wang R., Li D., Lin X.J., Wei Q.K., Yuan Y., Wang Q., Chen W. and Zhuang S.M. (2010). A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma. Hepatology 52, 1702-1712.
124. Zhang X., Liu S., Hu T., Liu S., He Y. and Sun S. (2009). Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology 50, 490-499.
125. Zhang J., Yang Y., Yang T., Liu Y., Li A., Fu S., Wu M., Pan Z. and Zhou W. (2010). microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br. J. Cancer 103, 1215-1220.
126. Zhang J.F., He M.L., Fu W.M., Wang H., Chen L.Z., Zhu X., Chen Y., Xie D., Lai P., Chen G., Lu G., Lin M.C. and Kung H.F. (2011). Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling. Hepatology 54, 2137-2148.
127. Zheng F., Liao Y.J., Cai M.Y., Liu Y.H., Liu T.H., Chen S.P., Bian X.W., Guan X.Y., Lin M.C., Zeng Y.X., Kung H.F. and Xie D. (2012). The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut 61, 278-289.
128. Zhu A., Xia J., Zuo J., Jin S., Zhou H., Yao L., Huang H. and Han Z. (2011). MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in gastric cancer. Med. Oncol. 29, 2701-2709.